HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique have begun locally-led HIV vaccine research ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...

The project, aptly named BRILLIANT, an acronym for “Bringing Innovation to Clinical and Laboratory Research to End HIV in ...

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

One of the most sought-after vaccines in medicine is the HIV vaccine. When HIV was first discovered in 1981, scientists were optimistic that they would be able to develop a vaccine in a few years.

The federal government yesterday formally announced the commencement of the HIV Vaccine Innovation, Science, and Technology ...

The study, published Oct. 11 in Science Immunology, removes one more barrier to developing a vaccine for HIV, and potentially other diseases such as malaria and cancer. Daniel Malouli, Ph.D ...

Human CMV gene blocks necessary T cell response; HIV vaccines engineered without the gene being tested in clinical trials ...